What does PatientSupportR do?

PatientSupportR is an IT company in Brussel. Private Limited, started on 16 October 2020, 2 establishments.

What is the address of PatientSupportR?

The registered office of PatientSupportR is located at de Meeûssquare 35, 1000 Brussel.

Is PatientSupportR still active?

Yes. According to the CBE (29 October 2026) PatientSupportR is active, legal situation “Normale toestand”, started on 16 October 2020.

Is PatientSupportR registered on Peppol?

Yes, PatientSupportR is registered on the Peppol network with ID 0208:0756705314.

What is the enterprise number of PatientSupportR?

The enterprise number of PatientSupportR is BE0756705314.

When was PatientSupportR founded?

PatientSupportR was founded on 16 October 2020.

Who are the directors of PatientSupportR?

According to the 2025 annual accounts, the directors of PatientSupportR are: Nadir21 BV, Dupont Healt Solutions Comm.V, I.V.S. NV.

Is PatientSupportR a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 October 2020; 4 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account; 2 establishments in the CBE.

How much profit did PatientSupportR make in 2025?

PatientSupportR recorded a loss after taxes of € 7,114 in financial year 2025.

What is the revenue of PatientSupportR?

As a small company, PatientSupportR is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 42,501.

Does PatientSupportR have a website?

Yes, PatientSupportR has a website at patientsupportr.eu.

PatientSupportR (Private Limited) - Brussel

Dossier PatientSupportR, printed on 29 October 2026 from databakkes.be/en/0756705314/patientsupportr. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 2 of the last 4 fiscal years.
Two loss years in a row NBB

Negative result in 2024 and 2025.
Tight liquidity NBB

Cash and receivables cover 10 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

PatientSupportR from Brussel, company number BE0756705314, closed financial year 2025 with a result of € -7,114 after tax. For that financial year PatientSupportR recorded a gross margin of € 42,501 and equity of € -168,637. Compared with financial year 2024, the result moved from € -176,045 to € -7,114. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 17, 2026.

What it is worth Caution

€ -168,637

▼ € 7,114 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -7,114

▲ 96 % less loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 17,442

▲ € 16,503 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -419,137.

Debts at end 2025

Bank debt

€ 1,502

▲ € 1,491 vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 108,354

▼ 20% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 1,942

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -14,351 Gross margin 2022: € -14,351 First fiscal year in the series	€ -94,565 Gross margin 2023: € -94,565 ▼ € 80,214 vs 2022 (€ -14,351) Unfavourable step	€ -123,572 Gross margin 2024: € -123,572 ▼ € 29,008 vs 2023 (€ -94,565) Unfavourable step	€ 42,501 Gross margin 2025: € 42,501 ▲ € 166,073 vs 2024 (€ -123,572) Favourable step	▲ € 166,073
Profit after taxes	€ -37,164 Profit after taxes 2022: € -37,164 First fiscal year in the series	€ -156,817 Profit after taxes 2023: € -156,817 ▼ € 119,653 vs 2022 (€ -37,164) Unfavourable step	€ -176,045 Profit after taxes 2024: € -176,045 ▼ € 19,228 vs 2023 (€ -156,817) Unfavourable step	€ -7,114 Profit after taxes 2025: € -7,114 ▲ € 168,931 vs 2024 (€ -176,045) Favourable step	▲ € 168,931
Equity	€ 115,839 Equity 2022: € 115,839 First fiscal year in the series	€ 14,522 Equity 2023: € 14,522 ▼ 87% vs 2022 (€ 115,839) Unfavourable step	€ -161,523 Equity 2024: € -161,523 ▼ € 176,045 vs 2023 (€ 14,522) Unfavourable step	€ -168,637 Equity 2025: € -168,637 ▼ € 7,114 vs 2024 (€ -161,523) Unfavourable step	▼ € 7,114
Total debts	€ 107,338 Total debts 2022: € 107,338 First fiscal year in the series	€ 169,653 Total debts 2023: € 169,653 ▲ 58% vs 2022 (€ 107,338) Unfavourable step	€ 284,714 Total debts 2024: € 284,714 ▲ 68% vs 2023 (€ 169,653) Unfavourable step	€ 262,078 Total debts 2025: € 262,078 ▼ 8% vs 2024 (€ 284,714) Favourable step	▼ 8%
Cash	€ 14,337 Cash 2022: € 14,337 First fiscal year in the series	€ 10,542 Cash 2023: € 10,542 ▼ 26% vs 2022 (€ 14,337) Unfavourable step	€ 939 Cash 2024: € 939 ▼ 91% vs 2023 (€ 10,542) Unfavourable step	€ 17,442 Cash 2025: € 17,442 ▲ € 16,503 vs 2024 (€ 939) Favourable step	▲ € 16,503
Retained profit	€ -79,161 Retained profit 2022: € -79,161 First fiscal year in the series	€ -235,978 Retained profit 2023: € -235,978 ▼ € 156,817 vs 2022 (€ -79,161) Unfavourable step	€ -412,023 Retained profit 2024: € -412,023 ▼ € 176,045 vs 2023 (€ -235,978) Unfavourable step	€ -419,137 Retained profit 2025: € -419,137 ▼ € 7,114 vs 2024 (€ -412,023) Unfavourable step	▼ € 7,114
Bank debt	€ 15 Bank debt 2022: € 15 First fiscal year in the series	€ 384 Bank debt 2023: € 384 ▲ € 368 vs 2022 (€ 15) Unfavourable step	€ 11 Bank debt 2024: € 11 ▼ 97% vs 2023 (€ 384) Favourable step	€ 1,502 Bank debt 2025: € 1,502 ▲ € 1,491 vs 2024 (€ 11) Unfavourable step	▲ € 1,491
Balance sheet total	€ 223,177 Balance sheet total 2022: € 223,177 First fiscal year in the series	€ 184,175 Balance sheet total 2023: € 184,175 ▼ 17% vs 2022 (€ 223,177) Unchanged	€ 123,191 Balance sheet total 2024: € 123,191 ▼ 33% vs 2023 (€ 184,175) Unchanged	€ 93,441 Balance sheet total 2025: € 93,441 ▼ 24% vs 2024 (€ 123,191) Unchanged	▼ 24%

Key figures of PatientSupportR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PatientSupportR?

What happened at PatientSupportR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 17, 2026 New annual accounts for financial year 2025: loss of € 7,114. Source: NBB ↗
Dec 15, 2021 New establishment in Zuienkerke. KBO
Oct 16, 2020 New establishment in Brussel. KBO
Oct 16, 2020 Start of the company according to the CBE. KBO

In short

From € 37,164 loss in 2022 to € 7,114 loss in 2025.

Original PDFs at the National Bank ↗

Management

Dupont Health Solutions 6.8%

ZENIT19 4.6%

I.V.S. - INTERNATIONAL VISUAL SERVICES

The stake of Dupont Health Solutions, ZENIT19, I.V.S. - INTERNATIONAL VISUAL SERVICES comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

PatientSupportR

Behind PatientSupportR are Nadir21 BV, Dupont Healt Solutions Comm.V and I.V.S. NV. The shares are held by Dupont Health Solutions (6.8%), ZENIT19 (4.6%) and I.V.S. - INTERNATIONAL VISUAL SERVICES.

Directors

According to the 2025 annual accounts

Nadir21 BV

Director · represented by Johan Uvin

Dupont Healt Solutions Comm.V

Director · represented by Vincent Dupont

Also active at: LIVELUNGER

I.V.S. NV

Director · represented by Carl Goosens

Shareholders

Dupont Health Solutions

6.8%

ZENIT19

4.6%

I.V.S. - INTERNATIONAL VISUAL SERVICES

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

de Meeûssquare 35

1000 Brussel

2.325.085.545

Blankenbergse Steenweg 10

8377 Zuienkerke

Active since 15 December 2021

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTP patientsupportr.eu

Technologies

CombellNginx

Hosting & Email

Email provider

Microsoft 365

Hosting

COMBELL-AS, BE

Domain

patientsupportr.eu

Registrar

Combell NV

Website info

HTTPS Nee

Features

Security

✗ HTTPS

✓ SPF

✗ DMARC

Details

Company number

0756.705.314

VAT number

BE 0756.705.314

Registered office

de Meeûssquare 35, 1000 Brussel

Names & denominations

PatientSupportR

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

16 October 2020

Peppol

Active · Active since 23 Dec 2025

Contact

patientsupportr.eu [email protected] 0478522527

Activities · NACE

Ontwerpen van computerprogramma’s

Ontwerpen en programmeren van computerprogramma's

Overige diensten op het gebied van informatietechnologie en computer

View on CBE Public ↗ Annual accounts (NBB) ↗

PatientSupportR

Warning lights

Financials

What happened to PatientSupportR?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Website

Technologies

Hosting & Email

Domain

Website info

Features

Security

Details

Frequently asked questions